Fibrosis or steatosis: which is the best screening target? Comment on the Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity

被引：0
|
作者：
Severo, Mateus Dornelles [1 ]
机构：
[1] Hosp Univ St Maria, Santa Maria, RS, Brazil
来源：
ARCHIVES OF ENDOCRINOLOGY METABOLISM | 2024年 / 68卷
关键词：
D O I：
10.20945/2359-4292-2024-0014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 4 条
  • [1] Fibrosis or steatosis: which is the best screening target? Comment on the Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity Reply
    Moreira, Rodrigo O.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68
  • [2] Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)
    Moreira, Rodrigo Oliveira
    Valerio, Cynthia Melissa
    Villela-Nogueira, Cristiane Alves
    Cercato, Cintia
    Gerchman, Fernando
    Lottenberg, Ana Maria Pita
    Godoy-Matas, Amelio Fernando
    Oliveira, Ricardo de Andrade
    Mello, Carlos Eduardo Brandao
    Alvares-da-Silva, Mario Reis
    Leite, Nathalie Carvalho
    Cotrim, Helma Pinchemel
    Parisi, Edison Roberto
    Silva, Giovanni Faria
    Miranda, Paulo Augusto Carvalho
    Halpern, Bruno
    Oliveira, Claudia Pinto
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2023, 67
  • [3] Fibrosis-4 score for screening of metabolic dysfunction-associated steatotic liver disease (MASLD): Data from a population-based sample in Tuscany
    Silverii, Giovanni Antonio
    Profili, Francesco
    Francesconi, Paolo
    Mannucci, Edoardo
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (10) : 2405 - 2408
  • [4] Longitudinal Follow-Up of Fibrosis-4 in Patients at Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease Receiving Low-Dose Methotrexate Treatment
    Cui, Jing
    Di Martino, Vincent
    Solomon, Daniel H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (11) : 2337 - 2339
1